Recipients
EFSD / Novo Nordisk Type 2 Diabetes Programme



2002 (over 3 years)

Peter Bergsten - Uppsala University, Sweden
Pathophysiology of impaired glucose-induced insulin secretion studied with islet linkage analysis

Ele Ferrannini - Pisa University, Italy
Beta cell dysfunction in type 2 diabetes: quantification, relation to insulin resistance and response to treatment

Jens Juul Holst - Copenhagen University, Denmark
The role of the incretin hormones in the pathogenesis and the treatment of type 2 diabetes and obesity

Leif Jansson - Uppsala University, Sweden
Islet blood flow and type 2 diabetes

Hubert Kolb - German Diabetes Institute - Düsseldorf, Germany
Immune gene expression and systemic inflammation in the pathogenesis of type 2 diabetes.

Massimo Porta - Turin University, Italy
Lifestyle intervention by group care in the management of type 2 diabetes. A randomised controlled multicentre clinical trial.

Erik Renström / Sebastian Barg - Lund University, Sweden
Identification and characterisation of a granular sulphonylurea receptor in the beta cell.

Michael Roden - Vienna University, Austria
Metabolic effects of long-term suppression of lipolysis in type 2 diabetes. Nuclear magnetic resonance spectroscopy and stable isotope studies

Frank J. Snoek - Free University Amsterdam, The Netherlands
Onset and recurrence of depression in older persons diagnosed with type 2 diabetes: Who is at risk? A prospective study

Anders Tengholm - Uppsala University, Sweden
Signalling networks for insulin secretion in individual pancreatic beta cells

Emile Van Schaftingen - Louvain Catholic University - Brussels, Belgium
Fructosamine 3-kinase, intracellular fructosamine removal and diabetes complications